Literature DB >> 2673240

Structure-activity relationship of endothelin: importance of charged groups.

K Nakajima1, S Kubo, S Kumagaye, H Nishio, M Tsunemi, T Inui, H Kuroda, N Chino, T X Watanabe, T Kimura.   

Abstract

Endothelin (ET)-related peptides including ET-1 (1-39) were synthesized, and their constricting activity in rat pulmonary artery rings and pressor activity in unanesthetized rat were measured to elucidate their structure-activity relationship. The vasoconstrictor activities of ET-2, ET-3 and sarafotoxin S6b were one-half, one-60th and one-third that of ET-1, respectively. Such differences in biological activities should mainly arise from sequence heterogeneity at the N-terminal portion, especially at positions 4 to 7. All of the blocked ETs at the amino or carboxyl termini showed greatly decreased activities. A monocyclic analog, in which Cys3 and Cys11 were replaced by Ala, showed one-third the activity of ET-1; however, its deamino dicarba analog was almost completely inactive. Significant activities were retained even with replacement of amino acids at positions Ser4, Ser5, Leu6, Met7, Lys9, Tyr13, and Trp21 by Ala, Ala, Gly, Met(0), Leu, Phe, and Tyr or Phe, respectively. On the other hand, replacement of Asp8, Glu10 and Phe14 by Asn, Gln and Ala, respectively, resulted in complete loss of the biological activity. These results indicated that two disulfide bonds in ET molecule were not essential for the expression of vasoconstricting activity. Both terminal amino and carboxyl groups, carboxyl groups of Asp8 and Glu10, and the aromatic group of Phe14 seemed to be contributing, more or less, to the expression of the biological activities.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673240     DOI: 10.1016/0006-291x(89)92153-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  Genome of deerpox virus.

Authors:  C L Afonso; G Delhon; E R Tulman; Z Lu; A Zsak; V M Becerra; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Design and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction.

Authors:  M J Spinella; A B Malik; J Everitt; T T Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 3.  Endothelins. Vascular actions and clinical implications.

Authors:  T Sakurai; K Goto
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

4.  Prediction of location of active sites in biologically active peptides.

Authors:  T Kikuchi
Journal:  J Protein Chem       Date:  1996-08

Review 5.  Privileged frameworks from snake venom.

Authors:  T A Reeks; B G Fry; P F Alewood
Journal:  Cell Mol Life Sci       Date:  2015-02-19       Impact factor: 9.261

6.  Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance.

Authors:  M Skolovsky; R Galron; Y Kloog; A Bdolah; F E Indig; S Blumberg; G Fleminger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog.

Authors:  Wataru Shihoya; Tomohiro Nishizawa; Keitaro Yamashita; Asuka Inoue; Kunio Hirata; Francois Marie Ngako Kadji; Akiko Okuta; Kazutoshi Tani; Junken Aoki; Yoshinori Fujiyoshi; Tomoko Doi; Osamu Nureki
Journal:  Nat Struct Mol Biol       Date:  2017-08-14       Impact factor: 15.369

8.  Activation mechanism of endothelin ETB receptor by endothelin-1.

Authors:  Wataru Shihoya; Tomohiro Nishizawa; Akiko Okuta; Kazutoshi Tani; Naoshi Dohmae; Yoshinori Fujiyoshi; Osamu Nureki; Tomoko Doi
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

9.  Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.

Authors:  A C Le Monnier de Gouville; I Cavero
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

10.  Endothelium-dependent mesenteric vasorelaxant effects and systemic actions of endothelin (16-21) and other endothelin-related peptides in the rat.

Authors:  S A Douglas; C R Hiley
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.